The current valuation score of Arcus Biosciences Inc is 7.43, ranking 225 out of 387 in the Biotechnology & Medical Research industry. Its current P/E ratio is -9.73, which is -83.31% below the recent high of -1.62 and -0.81% above the recent low of -9.81.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.